PMS-METHYLPHENIDATE CR

Identification of Pms-Methylphenidate Cr

No description

Google image searchProduct monograph

Active ingredient

methylphenidate hydrochloride, 30 MG

DIN: 02536986

Dosage form(s): CAPSULE (EXTENDED RELEASE)

Route(s) of administration: ORAL

Schedule: Schedule G (CDSA III)

Company: PHARMASCIENCE INC

Date: 30-OCT-2023

ATC:

• N06 — PSYCHOANALEPTICS (ATC, ATC/DDD, )
• N06B — PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS (ATC, ATC/DDD)
• N06BA — Centrally acting sympathomimetics (ATC, ATC/DDD)
• N06BA04 — METHYLPHENIDATE (ATC/DDD)

Reference brand drug: Biphentin, Concerta, Ritalin

Pharmaceutical standard: MFR

External Links for Pms-Methylphenidate Cr

Search on Google

• Pms-Methylphenidate Cr side effects
• Pms-Methylphenidate Cr dosage
• methylphenidate hydrochloride side effects
• methylphenidate hydrochloride dosage

Pharmascience Inc

Go to Pharmascience website to see drug product details. Sometimes you can find pms-methylphenidate cr photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.